CHANTELLE ALLEN: Open Payments
NPI 1942737010 · TERRE HAUTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$965 in 46 payments from 17 companies in 2025. Trend: 2023 $842 · 2024 $440 · 2025 $965
Food & beverage: $853Education: $111
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 13 | $181 |
| Teva Pharmaceuticals USA, Inc. | 4 | $179 |
| Axsome Therapeutics, Inc. | 5 | $112 |
| VERTEX PHARMACEUTICALS INCORPORATED | 4 | $102 |
| Otsuka America Pharmaceutical, Inc. | 3 | $85 |
| ABBVIE INC. | 3 | $62 |
| Alexion Pharmaceuticals, Inc. | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $30 |
| Valinor Pharma, LLC | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $25 |
Products named: Belbuca, JOURNAVX, REXULTI, Auvelity, UZEDY, Symbravo, UBRELVY, Jornay PM.
Industry payments across IN — which companies pay providers there.
